Gilead says remdesivir helped moderate COVID-19 patients improve

Gilead Sciences Inc said on Monday its antiviral drug remdesivir showed improvement in patients with moderate COVID-19 in a late-stage study. Read More

from Canoe https://ift.tt/2Mi9xRB